|
|
|
|
|
|
|
|
The Latest Research, Commentary, and News from Health Affairs
Wednesday, October 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
CULTURE OF HEALTH: HOUSING AND HEALTH
Registration Now Open!
November 7
9:00 am - 11:00 am Eastern
W Hotel Washington
515 15th Street NW, Washington DC
Register Today
Since 2015, Health Affairs has published important work related to a “Culture of Health.” The November 7 briefing will highlight the relationship between housing and health by featuring panels of contributing authors and practitioners who are meeting the challenges. Join this robust discussion on how community and place play an important role in promoting health and preventing disease.
View Speakers
Get event-specific emails delivered directly to your inbox.
|
|
|
|
|
A CLOSER LOOK—Alzheimer’s Disease
Drug company Biogen announced that it would seek FDA approval for aducanumab, a drug intended to treat early Alzheimer’s disease by helping clear plaque from the brain. In the April 2014 issue of Health Affairs, Jonathan Bor explored why it has proven so difficult to make progress toward a treatment and potential cure for the disease.
|
|
|
|
|
|
|
|
|
|
|
|
|
About Health Affairs
Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday
Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States
Privacy Policy
|
|
|
|
|
